Call Us + 33 1 84 88 31 00

Article R1245-17 of the French Public Health Code

Pursuant to the fourth paragraph of the I of Article L. 1245-5, when the elements or products mentioned in Article R. 1245-1 do not benefit from the authorisation mentioned in Article L. 1243-2, establishments or organisations planning to supply these elements or products to a Member State of the European Union or party to the Agreement on the European Economic Area must send the Agence nationale de sécurité du médicament…

Read More »

Article R1245-18 of the French Public Health Code

The Agence nationale de sécurité du médicament et des produits de santé has a period of four months to evaluate the information provided. At the end of these maximum four months, when, in application of the last paragraph of I of Article L. 1245-5, the Director General of the Agence nationale de sécurité du médicament et des produits de santé is considering prohibiting the departure from national territory of an…

Read More »

Article R1245-19 of the French Public Health Code

The provisions of Section 4 of Chapter V of Title III of this Book are applicable to the entry into and exit from national territory from or to a Member State of the European Union or party to the Agreement on the European Economic Area, to the import and export of tissues, their derivatives and cells of the human body defined in Article R. 1245-1 for scientific purposes.

Read More »

Article R1245-20 of the French Public Health Code

Manufacturers of in vitro diagnostic medical devices may import or export tissues, their derivatives and cells from the human body, whatever their level of processing, when these products are intended for the manufacture of in vitro diagnostic medical devices meeting the requirements to which they are subject for their marketing. The manufacturers concerned must declare their import activity to the Director General of the Agence nationale de sécurité du médicament…

Read More »

Article R1245-21 of the French Public Health Code

Manufacturers of in vitro diagnostic medical devices may procure tissues, their derivatives and cells from the human body, whatever their level of processing, in a Member State of the European Union or a party to the Agreement on the European Economic Area. These same establishments may supply tissues, their derivatives and cells from the human body, whatever their level of processing, to a Member State of the European Union or…

Read More »

Article R1245-23 of the French Public Health Code

I. – Applications for authorisation to import tissues, their derivatives or cells from the human body, whatever their level of processing, as provided for in the first paragraph of II of article L. 1245-5-1, are sent by pharmaceutical establishments and by establishments authorised under articles L. 4211-9-1 and L. 4211-9-2 to the Director General of the Agence nationale de sécurité du médicament et des produits de santé by any means…

Read More »

Article R1245-24 of the French Public Health Code

The Director General of the Agence nationale de sécurité du médicament et des produits de santé will give his decision within three months of receipt of the complete application by his departments. If no response is received by the end of this period, the authorisation is deemed to have been refused. The Director General of the Agence nationale de sécurité du médicament et des produits de santé may request any…

Read More »

Article R1245-25 of the French Public Health Code

The authorisations shall specify the elements listed in Annex II of Directive (EU) 2015/566. Authorisations issued in this way may be modified, suspended or withdrawn in whole or in part by the Director General of the Agence nationale de sécurité du médicament et des produits de santé under the conditions set out in Article L. 1245-1. A copy of the decisions to authorise, suspend or withdraw is sent to the…

Read More »

Article R1245-26 of the French Public Health Code

Any modification of the elements included in the initial import authorisation application dossier, concerning the nature or origin of the tissues, their derivatives or the cells imported, the activities carried out in third countries which may have an influence on the quality and safety of the tissues and cells imported or the suppliers established in these countries, is subject to an authorisation issued by the Director General of the Agence…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.